Course of molecular hemostatic markers during and after different surgical procedures

被引:32
作者
Siemens, HJG [1 ]
Brueckner, S [1 ]
Hagelberg, S [1 ]
Wagner, T [1 ]
Schmucker, P [1 ]
机构
[1] Univ Lubeck, Dept Internal Med 2, Subdiv Hematol, D-23538 Lubeck, Germany
关键词
blood; fibrinolytic markers; procoagulatory markers; cholecystectomy; hemicolectomy; surgery; thyroid resection; thrombophilic state; total hip replacement;
D O I
10.1016/S0952-8180(99)00119-1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Study Objective: To establish the most vulnerable time of thrombi formation with regard to the plasmatic (noncellular) part of the coagulatory and fibrinolytic systems. Design: Nonrandomized observational study. Setting: A surgical and an orthopedic unit and the central laboratory of a university hospital. Patients: 61 consenting ASA physical status I and II inpatients undergoing four different types of surgery: total hip replacement (THR): 16 patients; hemicolectomy: 15 patients; endoscopic cholecystectomy: 15 patients; subtotal thyroid resection: 15 patients. Interventions: The time course of 11 procoagulatory and fibrinolytic parameters was examined during the different types of surgery. Blood samples were drawn on the day before surgery, directly before the induction of general anesthesia, 1 to 2 hours postoperatively, and on the mornings of postoperative days 1, 2, 3, 4, and 5. Measurements and Main Results: The coagulation samples were centrifuged within 1 hour of collection of 2,300g for 15 minutes at 4 degrees C. Hemoglobin, hematocrit, platelets, fibrinogen, prothrombin time, activated partial thromboplastin time, thrombin time, antithrombin III, and protein C were determined immediately on laboratory arrival of the samples. The samples were aliquoted at -70 degrees C. They were thawed within 2 weeks and prepared for the following assays: thrombin-antithrombin III complexes (TAT-complexes), D-dimers, and plasminogen activator inhibitor type 1. Maximum activation of coagulation is not reached until 2 hours postoperatively and slowly decreases until normal values are reached around the fifth postoperative day. Parameters displaying the greatest changes are TAT-complexes and D-dimers. The type of surgery with the most pronounced changes was total hip replacement, followed by hemicolectomy, cholecystectomy, and subtotal thyroid resection. Conclusion: The total hip replacement and hemicolectomy groups show similar and strong activation of the procoagulatory and fibrinolytic systems. Much less pronounced are the changes during endoscopic cholecystectomy and subtotal thyroid resection. Maximum activation occurs 1 to 2 hours postoperatively. (C) 2000 by Elsevier Science Inc.
引用
收藏
页码:622 / 629
页数:8
相关论文
共 45 条
[21]   THROMBIN-ANTITHROMBIN-III-COMPLEX AND FIBRIN DEGRADATION PRODUCTS IN PLASMA - SURGERY AND POSTOPERATIVE DEEP VENOUS THROMBOSIS [J].
JORGENSEN, LN ;
LIND, B ;
HAUCH, O ;
LEFFERS, A ;
ALBRECHTBESTE, E ;
KONRADSEN, LAG .
THROMBOSIS RESEARCH, 1990, 59 (01) :69-76
[22]  
KAKKAR VV, 1995, THROMB HAEMOSTASIS, V74, P364
[23]   DEEP VEIN THROMBOSIS OF LEG - IS THERE A HIGH-RISK GROUP [J].
KAKKAR, VV ;
HOWE, CT ;
NICOLAIDES, AN ;
RENNEY, JTG ;
CLARKE, MB .
AMERICAN JOURNAL OF SURGERY, 1970, 120 (04) :527-+
[24]   ACTIVATION OF COAGULATION AND FIBRINOLYSIS DURING SURGERY, ANALYZED BY MOLECULAR MARKERS [J].
KAMBAYASHI, J ;
SAKON, M ;
YOKOTA, M ;
SHIBA, E ;
KAWASAKI, T ;
MORI, T .
THROMBOSIS RESEARCH, 1990, 60 (02) :157-167
[25]   PREVENTION OF THROMBOEMBOLISM IN HIP-FRACTURE PATIENTS - COMPARISON OF LOW-DOSE HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN COMBINED WITH DIHYDROERGOTAMINE [J].
LASSEN, MR ;
BORRIS, LC ;
CHRISTIANSEN, HM ;
MOLLERLARSEN, F ;
KNUDSEN, VE ;
BORIS, P ;
NEHEN, AM ;
JURIK, AG ;
DECARVALHO, A ;
NIELSEN, BW ;
LUCHT, U .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 1989, 108 (01) :10-13
[26]   HYPOFIBRINOLYSIS IN PATIENTS WITH HYPERCOAGULABILITY - THE ROLES OF UROKINASE AND OF PLASMINOGEN-ACTIVATOR INHIBITOR [J].
LAU, HKF ;
TEITEL, JM ;
CHEUNG, T ;
KUNG, SKP ;
GARVEY, MB .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 44 (04) :260-265
[27]  
LEVY PJ, 1994, J AM COLL SURGEONS, V178, P266
[28]  
LING HMS, 1986, LANCET, V1, P1173
[29]  
LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567
[30]  
MELLBRING G, 1985, ACTA CHIR SCAND, V151, P109